ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

IJMDC. 2025; 9(12): 3167-3173


Contrast-induced nephropathy following percutaneous coronary intervention at King Fahad Hospital of the University

Mahmoud Hassan, Rudaynah Alali, Abdullah H. Alnasser, Safia Makki Al Abbas, Komail Mohammed Alramadhan, Abdullah Yousef Alramadan, Ali Tahir Alwail, Mokhtar Hassan Al-Mohammad Ali, Abdullah Majed Alkhudair, Mohammed Waleed Almulhim, Ahmed Adnan Alsalman, Hussain Ali Albaqal, Mohammed AlMansouri, Sami Ghazal.



Abstract
Download PDF Post

Objective: This study aimed to determine the prevalence of contrast-induced nephropathy (CIN) among coronary artery disease (CAD) patients who had percutaneous coronary intervention (PCI) at least once previously and to determine patients who were at a higher risk of developing CIN at a single center in Saudi Arabia.
Methods: This was a retrospective study of patients diagnosed with CAD who underwent coronary angiography with PCI at King Fahad Hospital of the University (KFHU) between June 2022 and April 2024.
Results: The study included 298 patients; 6.7% of them developed CIN following PCI. Moreover, the risk of CIN was significantly higher in patients with type 2 diabetes undergoing PCI (univariate OR = 3.32 (1.25-10.43, p-value=0.024); multivariate OR = 10.09 (1.86-92.27, p-value=0.016)). Also, the level of creatinine before PCI significantly increased the risk of CIN (multivariate OR = 0.01 (0.00-0.13, p-value=0.001)).
Conclusion: CIN is recognized as a frequent complication after PCI, particularly in patients with diabetes mellitus.

Key words: Contrast-induced nephropathy, kidney injury, percutaneous coronary intervention, coronary artery disease, Saudi Arabia.







Bibliomed Article Statistics

45
2
R
E
A
D
S

21

1
D
O
W
N
L
O
A
D
S
0102
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.